Casa Verde Capital and Imperial Brands invest $10 million dollars in budding bio-pharmaceutical company, Oxford Cannabinoid Technologies. Their investment comes as the FDA gives the green light to the first marijuana-based medicine. Casa Verde Capital Managing Partner Karan Wadhera gets into the weeds of the deal with Bloomberg's Abigail Doolittle. (Source: Bloomberg)